Hapvida Shares Rise 9.2% After 1Q Results Beat Expectations
By Jeffrey T. Lewis
SÃO PAULO-- Hapvida Participações e Investimentos' shares rose after the Brazilian hospital and clinic operator's first-quarter results topped estimates.
The stock rose 9.2% to 3.44 reais, the equivalent of 70 cents, and were down 38% from the end of last year through Monday's close. Brazil's benchmark Ibovespa stocks index was up 0.2% in mid-afternoon trading.
Hapvida said Monday after the close that net revenue rose 13% from the first quarter of 2022, while adjusted net income declined 6.3% in the same period.
Analysts at Itaú BBA said the company's adjusted earnings before interest, taxes, depreciation and amortization came in 19% higher than their estimates. Hapvida also delivered solid improvement in both working capital and capital spending, and didn't book any non-recurring items for expenses for the first time in a few quarters, Itaú BBA said.
Write to Jeffrey T. Lewis at jeffrey.lewis@wsj.com
(END) Dow Jones Newswires
May 16, 2023 13:39 ET (17:39 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening In the Markets This Week
-
Can the Fed Declare Victory on Inflation?
-
3 Warren Buffett Stocks to Buy After Berkshire Hathaway’s Just-Released 13F Filing
-
Going Into Earnings, Is Nvidia Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Arista Stock a Buy, a Sell, or Fairly Valued?
-
A Cheap Dividend Aristocrat to Buy Before It Bounces Back
-
Alibaba Earnings: More Positive Outlook Despite Mixed Results
-
After Earnings and a 56% Rally In 2024, Is Arm Stock a Buy, a Sell, or Fairly Valued?
-
How Morningstar Rates Stocks
-
After Earnings, Is Disney Stock a Buy, a Sell, or Fairly Valued?